Filtered by:
45 Programs
-
Year in Review
Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Antibody-Drug Conjugates for Breast Cancer
-
-
H
-
S
-
H
-
-
H
-
S
-
H
+1 more module
-
-
SABCS Proceedings 2025
Cases from the Community: Investigators Discuss the Role of Antibody-Drug Conjugates in the Management of Triple-Negative and HR-Positive Metastatic Breast Cancer
-
-
J
-
P
-
P
- +1
-
J
-
-
SABCS Proceedings 2025Cases from the Community: Investigators Discuss the Optimal Role of Endocrine-Based and Other Strategies in the Management of HR-Positive Breast Cancer
-
-
A
-
E
-
H
- +2
-
A
-
-
SABCS Proceedings 2025
Cases from the Community: Investigators Discuss the Optimal Management of HER2-Positive Breast Cancer
-
-
I
-
J
-
N
- +2
-
I
-